Aridis Pharmaceuticals (ARDS) Withdraws Proposed Stock Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. NXPI
4. SPY
5. BA
6. STX
7. NOW
8. GOOGL
9. V
10. CSGP

Go back to Aridis Pharmaceuticals (ARDS) Withdraws Proposed Stock Offering

Aridis Pharmaceuticals Announces Withdrawal of Public Offering of Common Stock

September 27, 2022 9:20 AM EDT

LOS GATOS, Calif., Sept. 27, 2022 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today announced that due to adverse market conditions, it has withdrawn its proposed public offering of shares of its common stock.

"Due to the current market environment and in the interest of achieving the best value for our stockholders, we have decided to withdraw our recently announced public offering of common stock... More